GI

Age, sex, activity, genetic phenotype, stress, disease (eg, achlorhydria, malabsorption syndromes), or previous GI surgery can affect drug bioavailability.

年龄、性别、活动情况、遗传表型、激、疾病（如胃酸缺乏,营养不良综合征）或既往胃肠手术等均能影响药物的生物利用度。

In addition, mercury results in secondary problems as discussed such as immuno-suppression, allowing for opportunistic infections, allergies, GI dysbiosis, etc.

另外，汞的次发性问题如免疫抑，机会性感染，过敏，肠胃道坏菌增生等等。